After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Discover effective ways to make money quickly to pay debts. Regain financial stability with practical and fast solutions.
21,535 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Open USD was unveiled on June 30, 2026, promising zero-cost minting and a reserve-sharing model. The plan aims to pus...
Investors are turning away from Hewlett Packard Enterprise as a dividend-rich tech giant with a clearer AI roadmap ga...
Internal documents reveal OpenAI posted $21B in losses on $13B in revenue, signaling a costly push to scale AI at bre...
A high-profile crypto policy debate erupts as Eli Ben-Sasson questions Bitcoin’s 21 million cap and proposes a fixed ...
Choosing between broad healthcare exposure and a focused pharmaceutical sleeve can shape your portfolio for years. Th...
A new wave of defense investing is shifting capital away from traditional U.S. contractors toward allied and private ...
London-based Valarian secures a $50 million Series A led by NEA to deploy ACRA, a sovereignty-focused layer that lets...
In 2026, four Dividend Kings are outperforming the S&P 500 as investors pivot to cash-flow creators. The move signals...
Bitcoin and Ethereum cling to crucial support as Congress prepares to grill the Clarity Act. July eyes are on a poten...
A retirement planner explains how one misstep on required minimum distributions can push Medicare bills higher throug...
Renewed Iran tensions push Treasury yields higher and lift mortgage costs, threatening affordability for buyers and h...